Comparison of neonatal outcomes with use of a soybean oil-based injectable lipid emulsion vs a 4-oil emulsion product.
CONCLUSION: In preterm neonates weighing 500 to 2,000 g, use of SMOFlipid did not significantly reduce the incidence of cholestasis or hypertriglyceridemia relative to the incidence with use of SO-ILE. Further research to validate these results is needed.
PMID: 33480407 [PubMed - in process]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Hudgins DK, Holmes AP, Parman MG, Harris JB Tags: Am J Health Syst Pharm Source Type: research
More News: Cholestasis | Drugs & Pharmacology | Intensive Care | Nutrition | Parenteral Nutrition | Perinatology & Neonatology | Statistics | Study